With an outstanding track record in multinational healthcare companies, the new advisor will drive the global growth of the company and the positioning of its innovative technology for visual simulation of presbyopia and cataracts.
2EyesVision continues to strengthen its global positioning with the appointment of Máximo Gómez as strategic operating advisor. His arrival marks a decisive step in the company’s international expansion roadmap, at a key moment for the healthcare sector, where technology, treatment personalization, and patient experience set the competitive edge. Gómez joins the team with the goal of consolidating 2EyesVision’s presence in new markets and accelerating the adoption of its visual simulation technology in leading ophthalmology clinics worldwide.
What is a strategic operating advisor?
A strategic operating advisor is an executive profile who acts as a key consultant for companies in phases of growth, scaling, or operational transformation. They provide strategic vision, market knowledge, operational experience, and a network of contacts to optimize processes, boost new business lines, or facilitate internationalization. In highly regulated sectors such as healthcare, their role is essential to anticipate challenges, align objectives, and implement expansion plans effectively and robustly.
A strategic addition with international experience
Máximo Gómez has built a career of more than two decades in leading healthcare companies such as Johnson & Johnson and Abbott Laboratories. At Johnson & Johnson Vision, he led operations in Iberia and later the Southern Europe region, including strategic markets such as Spain and Italy, with over €70 million in annual sales. His ability to lead multidisciplinary teams, drive commercial performance, and execute high-impact strategies will be key to 2EyesVision’s next steps.
“2EyesVision’s technology has the potential to transform how intraocular lenses are selected in refractive and cataract surgery. I’m excited to contribute to its global expansion and to improving clinical outcomes and patient experience,” says Máximo Gómez.
2EyesVision’s flagship solution is a binocular simulator for presbyopia and cataracts that allows patients to experience, before surgery, how they will see with different types of intraocular lenses. This technology improves clinical decision-making, reduces patient uncertainty, and contributes to a more personalized and effective surgery. Clinically validated and positively received by specialists in Europe and the Americas, the simulator is positioned as a high-potential tool for global adoption.
This strategic reinforcement is part of a growth phase funded by Bullnet Capital and Innvierte-CDTI. The funds are aimed at operational scalability, the development of new markets, and team strengthening. In this context, having an advisor with international vision, such as Máximo Gómez, offers a competitive edge in facing the regulatory, logistical, and commercial challenges of global expansion.
Future vision and sectoral impact
The addition of a profile with extensive experience in health and international leadership marks a turning point in the company’s positioning as a reference in visual simulation. The combination of disruptive technology, strategic capital, and senior talent places 2EyesVision in a privileged position to lead the future of personalized ophthalmology.
Would you like to know how visual simulation technology can improve clinical outcomes in your clinic or practice?
Get in touch with us and discover how to take the next step toward personalized surgery.
0 Comments